The Messiness of Medical Decision Making in Advanced Illness: A Podcast with James Tulsky
Anyone who cares for individuals with serious illness must live in a messy space where tough conversations about treatment decisions…
I read Farah Stockman’s article in the NYT on why attacks on DEI will cost us all, and thought, “Yes,…
Anyone who cares for individuals with serious illness must live in a messy space where tough conversations about treatment decisions…
“The secret sauce of the Transitions, Referral and Coordination (TRAC) team was including a lawyer.” This is brilliant and will…
Most studies in geriatrics have used metrics such as survival time or disability in activities of daily living as their…
The FDA label for the amyloid antibody aducanumab (Aduhelm) started off exceedingly broad, basically including anyone with Alzheimer’s disease, but…
“The take home message of this study is NOT that primary palliative care does not work.” So says Yael Schenker of…
Time-limited trials. We’ve all probably used them before. We meet with patients and families. We agree to either start or…
I’m going to start this introduction the way Eric ended our podcast. You are a GeriPal listener. Like us, you…
Randy Curtis, a paragon of palliative care research, was diagnosed with ALS in March. Randy is in a unique position…
Palliative care has a diversity problem. The workforce of palliative care looks nothing like the patient population that we care…
Much has been written in geriatrics and palliative care about anticipatory grief, about the grief of caregivers, and even the…